Dr Luis Nacul
of epidemiology and public health (clinical)
I have wide experience in public health, epidemiology and in general practice and medicine, having worked at health services and in clinical and public health research in Brazil, before joining the School, where I now work as a part-time Clinical Associate Professor in epidemiology and public health.
My main research interests are in ME/CFS and in chronic diseases and disability more generally. I direct the CureME research group (http://cureme.lshtm.ac.uk/) contributing with my clinical, epidemiological and public health skills to our multi-disciplinary research into ME/CFS, in partnership with experts from 3 Departments at the School and with people with ME/CFS. One of our flagship projects has been the UK ME/CFS Biobank, one of the pioneer biobank facilities in the world for the study of ME/CFS, which functions as an open resource for research in both ME/CFS and MS.
Other interests include in congenital disorders and zika virus infection, with emphasis on the impact of disability and on interventions aiming at reducing disease incidence and morbidity. My activities in these fields have included leading on the creation of a toolkit for Health Needs Assessment in Congenital Disorders in Low and Middle-Income Countries (http://www.bornhealthy.org/toolkit.html) and participation in the Zika-Alliance consortium (https://zikalliance.tghn.org/).
My main teaching has been in epidemiology and public health. I was one of the first course organisers for the Epidemiology MSc by Distant Learning with contribution to various teaching modules. I have supervised a number of post-graduate students in the UK and overseas.
I am the principal investigator for the National INstitutes of Health (US)-funded study ‘A longitudinal immunological and virological study for ME CFS biomarker discovery’; and for the ME Assocaitionfunded study on "UK ME/CFS Biobank: Opening our Doors") I have previously been the principal investigator for the feasibility studies on establishing a disease-specific post-mortem tissue bank and Biobank for the study of ME/CFS, which helped shape the current NIH-funded project. Previously I had been the London lead for the CFS/ME Observatory project, which encompassed a number of studies on the epidemiology, health services and social aspects of ME/CFS.